{"id":"https://openalex.org/W2485518137","doi":null,"title":"[Pharmacological modulation of the effects induced by ketamine at subanesthetic doses].","display_name":"[Pharmacological modulation of the effects induced by ketamine at subanesthetic doses].","publication_year":2001,"publication_date":"2001-09-01","ids":{"openalex":"https://openalex.org/W2485518137","mag":"2485518137","pmid":"https://pubmed.ncbi.nlm.nih.gov/11806303"},"language":"fr","primary_location":{"id":"pmid:11806303","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11806303","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapie","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040208100","display_name":"Anwar Mechri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166928557","display_name":"University of Monastir","ror":"https://ror.org/00nhtcg76","country_code":"TN","type":"education","lineage":["https://openalex.org/I166928557"]}],"countries":["TN"],"is_corresponding":false,"raw_author_name":"A Mechri","raw_affiliation_strings":["Service de Psychiatrie, H\u00f4pital Universitaire de Monastir, 5000 Monastir, Tunisie"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de Psychiatrie, H\u00f4pital Universitaire de Monastir, 5000 Monastir, Tunisie","institution_ids":["https://openalex.org/I166928557"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016176687","display_name":"Jo\u00eblle Micallef","orcid":"https://orcid.org/0000-0002-7172-7835","observed_orcids":["https://orcid.org/0000-0002-7172-7835"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Micallef","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108088008","display_name":"Olivier Blin","orcid":"https://orcid.org/0000-0003-0142-0931","observed_orcids":["https://orcid.org/0000-0003-0142-0931"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"O Blin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010304110","display_name":"Mohamed Saoud","orcid":"https://orcid.org/0000-0002-9901-8846","observed_orcids":["https://orcid.org/0000-0002-9901-8846"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Saoud","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079576731","display_name":"J Dal\u00e9ry","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Dal\u00e9ry","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5073728946","display_name":"Lotfi Gaha","orcid":"https://orcid.org/0000-0003-0954-2036","observed_orcids":["https://orcid.org/0000-0003-0954-2036"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Gaha","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1853,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.591835,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"56","issue":"5","first_page":"617","last_page":"22"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.8740000128746033,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.8740000128746033,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0778999999165535,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.008500000461935997,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ketamine","display_name":"ketamine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/subanesthetic-doses","display_name":"subanesthetic doses","score":0.8320000171661377},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.7799999713897705},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.8799999952316284},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.593999981880188},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.7369999885559082},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.972000002861023},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.996999979019165},{"id":"https://openalex.org/keywords/lamotrigine","display_name":"lamotrigine","score":0.8769999742507935},{"id":"https://openalex.org/keywords/lorazepam","display_name":"lorazepam","score":0.9789999723434448},{"id":"https://openalex.org/keywords/psychotic-symptoms","display_name":"psychotic symptoms","score":0.6140000224113464},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.7879999876022339},{"id":"https://openalex.org/keywords/executive-function","display_name":"executive function","score":0.7329999804496765},{"id":"https://openalex.org/keywords/perceptual-alterations","display_name":"perceptual alterations","score":0.5249999761581421},{"id":"https://openalex.org/keywords/pharmacological-modulation","display_name":"pharmacological modulation","score":0.6050000190734863}],"concepts":[{"id":"https://openalex.org/C2780795376","wikidata":"https://www.wikidata.org/wiki/Q243547","display_name":"Ketamine","level":2,"score":0.8937581777572632},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.8303970098495483},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.7667856812477112},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.7587103843688965},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.6282815933227539},{"id":"https://openalex.org/C2778802184","wikidata":"https://www.wikidata.org/wiki/Q410346","display_name":"Lamotrigine","level":3,"score":0.6155600547790527},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.585451602935791},{"id":"https://openalex.org/C2779706987","wikidata":"https://www.wikidata.org/wiki/Q408265","display_name":"Lorazepam","level":2,"score":0.48469212651252747},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4684866666793823},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4655528664588928},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4589345157146454},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.454105943441391},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.39460664987564087},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2210237681865692},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.18012088537216187},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1714560091495514},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.1402745544910431},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.112143874168396},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000778","descriptor_name":"Anesthetics, Dissociative","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000778","descriptor_name":"Anesthetics, Dissociative","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:11806303","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11806303","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapie","raw_type":"English Abstract"},{"id":"mag:2485518137","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11806303","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2077609442","https://openalex.org/W2026621438","https://openalex.org/W1972253384","https://openalex.org/W2086593869","https://openalex.org/W1875432782","https://openalex.org/W2142477907","https://openalex.org/W2013101829","https://openalex.org/W2029925498","https://openalex.org/W1987285132","https://openalex.org/W2119779293"],"abstract_inverted_index":{"The":[0],"similarity":[1],"between":[2],"ketamine":[3,19],"effects":[4,87,108],"and":[5,35,41,48,73],"endogenous":[6],"psychoses":[7],"has":[8,96],"created":[9],"interest":[10],"in":[11,61],"the":[12,86,107],"capacity":[13],"of":[14,28,81,88,106,109,120],"antipsychotic":[15],"medications":[16],"to":[17,44,57,99,118],"block":[18,45],"effects.":[20],"In":[21,76],"healthy":[22],"subjects,":[23,78],"a":[24],"sub-anaesthetic":[25],"single":[26,79],"dose":[27],"lorazepam,":[29],"typical":[30],"neuroleptics,":[31,37],"such":[32,38,113,127],"as":[33,39,114,128],"haloperidol,":[34],"atypical":[36],"clozapine":[40,95],"olanzapine,":[42],"failed":[43],"ketamine-induced":[46,59,68,101],"positive":[47,102],"negative":[49],"symptoms":[50],"resembling":[51],"schizophrenia.":[52,129],"However,":[53,90],"haloperidol":[54],"is":[55],"able":[56],"decrease":[58,85,100],"impairment":[60],"executive":[62],"cognitive":[63,74],"functions.":[64],"Recently,":[65],"lamotrigine":[66],"reduced":[67],"psychotic":[69],"symptoms,":[70],"perceptual":[71],"alterations,":[72],"impairments.":[75],"schizophrenic":[77],"doses":[80],"olanzapine":[82],"do":[83],"not":[84],"ketamine.":[89],"long":[91],"term":[92],"treatment":[93],"with":[94],"been":[97],"reported":[98],"symptoms.":[103],"Pharmacological":[104],"modulation":[105],"NMDA":[110],"receptor":[111],"antagonists,":[112],"ketamine,":[115],"may":[116],"lead":[117],"development":[119],"novel":[121],"therapeutic":[122],"agents":[123],"for":[124],"psychiatric":[125],"illnesses":[126]},"counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-08-23T00:00:00"}